U.S. Senate Calls For Stability of Ag Biotech Amid Trade Negotiations with China
Over a third of the U.S. Senate led by Sen. Pat Roberts, Chairman of the
U.S. Senate Committee on Agriculture, Nutrition and Forestry, expressed
their concern over delays in China's approval process for agri-biotech
products in a letter addressed to President Donald Trump. Despite previous
agreements, China has failed to make the necessary revisions to their
regulatory system that would provide a stable trade environment for U.S.
producers, technology providers, and exporters.
In light of ongoing trade negotiations with China, the senators also urged
President Trump to capitalize on his forthcoming meeting with President Xi
to resolve crucial trade issues and reach an agreement for a "timely,
transparent, and science-based system for the approvals of agriculture